Header Logo

Connection

Jonathan Eskenazi to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Jonathan Eskenazi has written about Antibodies, Monoclonal, Humanized.
Jonathan Eskenazi
Connection Strength
0.177
Antibodies, Monoclonal, Humanized
  1. Improvement of Comorbid Psoriasis in Patients With MS Treated With Natalizumab. Neurol Neuroimmunol Neuroinflamm. 2021 03; 8(2).
    View in: PubMed
    Score: 0.177
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.